Microalbuminuria as an Independent Risk Factor for Developing Concentric Left Ventricular Hypertrophy in Primary

Sayyid Moidu1, Akash T Oomen1, Gopalakrishna Pillai1

  • 1Internal Medicine, Amrita Institute of Medical Sciences and Research Centre, Kochi, IND.

Cureus
|February 15, 2022
PubMed

Insights

Microalbuminuria is a reliable marker for predicting concentric left ventricular hypertrophy (LVH) in primary hypertension patients. High serum creatinine and diastolic blood pressure also independently predict concentric LVH.

Area of Science:

  • Cardiology
  • Nephrology
  • Hypertension Research

Background:

  • Microalbuminuria and concentric left ventricular hypertrophy (LVH) are recognized complications of primary hypertension.
  • Understanding the relationship between these conditions is crucial for managing hypertensive heart disease.

Purpose of the Study:

  • To assess if microalbuminuria is an independent risk factor for concentric LVH in primary hypertension.
  • To explore other biomarkers associated with concentric LVH in this patient group.

Main Methods:

  • A single-center observational study included adult patients with primary hypertension.
  • Data collected on microalbuminuria, LVH, serum creatinine, and diastolic blood pressure.

Main Results:

  • Microalbuminuria showed a significant association with concentric LVH (p=0.003).
  • Multivariate analysis identified microalbuminuria, serum creatinine, and high diastolic blood pressure as independent risk factors for concentric LVH (p<0.001, 0.016, 0.016).

Conclusions:

  • Microalbuminuria serves as a dependable predictor of concentric LVH in primary hypertension.
  • Elevated serum creatinine and diastolic blood pressure are also significant independent risk factors for concentric LVH.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
67
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
116
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
130
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
842